Journals / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 4

Prognostic Factors and Clinical Outcomes of Hospitalized Cancer Patients Diagnosed with COVID-19 Infection: Single Center Experience

Pages
454–459
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, medical follow-up of patients with 4 or more metastases is of particular importance

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Several studies have demonstrated that COVID-19 infection has been related with poor prognosis in can- cer patients.
📊
Key Findings & Data:On account of these findings, we aimed to analyze cancer patients infected with COVID-19 in terms of their laboratory and clinical findings.
💡
Conclusion & Impact:Therefore, medical follow-up of patients with 4 or more metastases is of particular importance
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Several studies have demonstrated that COVID-19 infection has been related with poor prognosis in can- cer patients. On account of these findings, we aimed to analyze cancer patients infected with COVID-19 in terms of their laboratory and clinical findings. The relationship between the number of metastases with the outcome of COVID-19 infection was also examined. Methods: A total of 56 patients—with 25 females and 31 males—were enrolled in this retrospective study. The pres- ence of COVID-19 infection was proven through the use of nasopharyngeal swab and PCR technique laboratory tests. Diagnosis of cancers were confirmed with pathological findings on the biopsy or surgery specimens. The IBM SPSS Statistics 26.0 program was used in the statistical analysis of the research. Results: Existence of 4 or more metastases were found in 21 patients who died during their follow-up period (p=0.000), as well as increased serum ferritin levels with a median of 905.3 ng/ml in death patients as compared to 173.1 ng/ml in surviving patients (p=0.01). Other laboratory findings that were found statistically significant between non-surviving and surviving patients, older age and being of the male gender were accepted as worse prognostic factors in this study. In addition, 15 of 26 non-surviving patients who received chemotherapy in their last month had worse prognosis than patients who had received chemotherapy more than one month ago (p=0.045). Conclusion: As a result, the management of cancer patients during the pandemic process, and particularly those with widespread metastasis, is quite challenging. Therefore, medical follow-up of patients with 4 or more metastases is of particular importance

🔖

Cite This Article

Yildirim, A., Acun, L. D. (2022). Prognostic Factors and Clinical Outcomes of Hospitalized Cancer Patients Diagnosed with COVID-19 Infection: Single Center Experience. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 4, 454–459. https://ajindex.com/articles/508567

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Berber I, Cagasar O, Sarici A, Berber NK, Aydogdu I, Ulutas O, et al. Peripheral blood smear findings of COVID-19 patients provide information about the severity of the disease and the duration of hospital stay. Mediterr J Hematol Infect Dis 2021;13:e2021009
  2. Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, et al. Clinical characteristics, outcomes, and risk factors for mortality in pa- tients with cancer and COVID-19 in Hubei, China: a multicen- tre, retrospective, cohort study. Lancet Oncol 2020;21:904–13
  3. Berber NK, Ulutas Ö, Sarıcı A, Yıldırım A, Çağaşar Ö, Gözükara H, et al. Clinical features and laboratory values associated with disease severity in Covid-19 patients: a single center experi- ence. J Health Sci Med 2021;4:18–22
  4. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20
  5. Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS- CoV-2. Eur J Nucl Med Mol Imaging 2020;47:1275–80 6. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemio- logical and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13
  6. Jindal V, Sahu KK, Gaikazian S, Siddiqui AD, Jaiyesimi I. Cancer treatment during COVID-19 pandemic. Med Oncol 2020;37:58
  7. Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. Prognostic factors for severity and mortal- ity in patients infected with COVID-19: A systematic review. PLoS One 2020;15:e0241955
  8. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2020:ciaa270
  9. Gómez-Pastora J, Weigand M, Kim J, Wu X, Strayer J, Palmer AF, et al. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic media- tor? Clin Chim Acta 2020;509:249–51
  10. Song A, Eo W, Kim S, Shim B, Lee S. Significance of serum fer- ritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study. BMC Complement Altern Med 2018;18:176
  11. Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Aust Prescr 2015;38:93–4
  12. Sprangers B, Sandhu G, Rosner MH, Tesarova P, Stadler WM, Malyszko J. Drug dosing in cancer patients with decreased kidney funct